← Eichor
Study identifier: NCT06508268 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease

Condition: Alzheimer's Disease · MCI Due to AD · Dementia Alzheimers  ·  Sponsor: Hanze University of Applied Sciences Groningen

PhaseN/A
Planned participants208
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

The goal of this observational cross-sectional study is to explore the characteristics of language, speech, and motor function in persons with Mild Cognitive Impairment due to Alzheimer's disease ("MCI due to AD") and persons with mild and moderate Alzheimer's disease ("AD"). This study aims to: * Explore motor, speech, and language functions in MCI due to AD and mild and moderate AD. * Combine the characteristics of motor, language, and speech functions to gain more insight into the association of language, speech, and motor changes during MCI due to AD and mild and moderate AD. Researchers will compare the outcomes to an age-matched control group without cognitive impairment. Participants will undergo: * Two motor function tests to assess gait and hand grip strength. * Four language and speech function tests to assess spontaneous speech and verbal fluency..

This description comes directly from the study's public registry record.

Talk to the study team

Marlies Oegema, Master  ·  0031+0505953730  ·  m.oegema@pl.hanze.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Hanze UniversityGroningen, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06508268